India  

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

IndiaTimes Tuesday, 13 April 2021 ()
Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations. The permission is subject to provisions of New Drug and Clinical Trials Rules 2019 under the Drugs and Cosmetics Act.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Doctors welcome India's approval to 'Sputnik V' vaccine

Doctors welcome India's approval to 'Sputnik V' vaccine 01:50

Subject Expert Committee of union government on April 12 approved Dr Reddy's application for emergency use authorisation to Russian COVID vaccine 'Sputnik V' in India. With this, India has now three COVID-19 vaccines in use. Welcoming the step, Medical Superintendent of RML Hospital, Dr Rana AK Singh...

You Might Like


💡 newsR Knowledge: Other News Mentions

Dr. Reddy's Laboratories Indian multinational pharmaceutical company

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head [Video]

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head

Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a minus 18-degrees Celsius storage vaccine. We have created a state-of-the-art central warehouse that operates below minus 20-degrees Celsius. These are single-dose ampules, once taken out have to be administered within 30 mins," informed Head of global logistics at Dr. Reddy's lab.

Credit: ANI    Duration: 01:43Published
Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO [Video]

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO

The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today, we have received 1,50,000 doses of Sputnik V vaccine here in Hyderabad. The vaccine will be available in a few weeks after it has gone through statutory clearances. The price will also be announced then," said CEO Sapra.

Credit: ANI    Duration: 01:02Published
150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News [Video]

150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News

Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's Laboratories, and soon to be distributed among the healthcare systems of the country. #covid19 #covid vaccines #SputnikV #Russia #Indiacovidcrisis

Credit: Oneindia    Duration: 01:01Published

Sputnik V COVID-19 vaccine Sputnik V COVID-19 vaccine Vaccine against COVID-19

Slovaks divided over Russia's Sputnik V vaccine after quality concerns [Video]

Slovaks divided over Russia's Sputnik V vaccine after quality concerns

Many Slovaks have told Euronews they still trust Russia's Sputnik V vaccine, despite a dispute over its quality.

Credit: Euronews English    Duration: 02:27Published

First lot of 1.5 lakh Sputnik V doses lands in India

On a day that India threw open vaccinations to all citizens over 18 years of age, the first lot of 1.5 lakh Russian Covid-19 vaccines Sputnik V arrived in..
IndiaTimes

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Singer Sonu Nigam donates blood amid COVID crisis [Video]

Singer Sonu Nigam donates blood amid COVID crisis

Singer Sonu Nigam inaugurated the blood donation camp organised by Ameet Satam's Adarsh Foundation at Bharatmata Hall, Vidyanidhi campus in Juhu. He donated blood and urged his fans to donate blood amid the second wave of COVID-19. The singer became the first blood donor of the two-day camp set up in Juhu and he also motivated the youth to donate blood before taking the vaccination. Sonu Nigam had tested COVID positive earlier.

Credit: ANI    Duration: 02:53Published
Locals arrive at govt-run liquor shops to buy alcohol amid COVID lockdown [Video]

Locals arrive at govt-run liquor shops to buy alcohol amid COVID lockdown

Tamil Nadu government had imposed fresh COVID-19 restricts in order to curb the spread of the novel coronavirus. Government had also extended night curfew and Sunday lockdowns till further orders. Government-run TASMAC liquor shops have been permitted to operate between 8 am and noon till May 20. Locals thronged the shops on the morning of May 06 to get their dose of alcohol.

Credit: ANI    Duration: 01:19Published
COVID testing: Long queue outside Moradabad Railway Station as people await for officials to arrive [Video]

COVID testing: Long queue outside Moradabad Railway Station as people await for officials to arrive

In wake of COVID-19 spread, testing has been ramped up by governments. A long queue was seen at Moradabad Railway Station as people waited for health officials to arrive and begin the testing. People complained that they have been standing in queue since morning but administration is delaying the testing process. Later, lab technician informed that due to unavailability of transport, they could not reach on time.

Credit: ANI    Duration: 02:02Published
3,980 people succumb to COVID, highest single day deaths [Video]

3,980 people succumb to COVID, highest single day deaths

Once again India crossed the 4-lakh mark in daily spike of COVID-19 cases after reporting 4,12,262 new infections in last 24 hours. COVID caseload of the country stood at 2,10,77,410, with 35,66,398 active cases. Death toll continues to mount as India reported highest single day deaths. 3,980 fatalities were reported in last 24 hours taking the total death toll to 23,01,68. Total of 1,72,80,844 people have won the battle against the deadly virus. Vaccination drive is underway across country. So far 16,25,13,339 doses have been administered.

Credit: ANI    Duration: 01:24Published

Drugs Controller General of India Drugs Controller General of India

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases [Video]

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now. This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.

Credit: ANI    Duration: 02:01Published

Related videos from verified sources

Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other..

Credit: ANI     Duration: 01:57Published
'UK is a solid friend', says EAM on India-UK summit [Video]

'UK is a solid friend', says EAM on India-UK summit

Calling UK "a solid friend", EAM Dr S Jaishankar on India-UK relationship said that India is getting oxygen plants, oxygen concentrators, cylinders to address the oxygen challenge, cryogenic tanks, and..

Credit: ANI     Duration: 02:11Published
Covid talks: Jaishankar meets Biden aide Blinken in London, discusses vaccine [Video]

Covid talks: Jaishankar meets Biden aide Blinken in London, discusses vaccine

India's external affairs minister Subrahmanyam Jaishankar met US Secretary of State Antony Blinken in London on May 3. The two discussed the Covid-19 pandemic, and vaccine production, as India faces..

Credit: HT Digital Content     Duration: 01:41Published

Related news from verified sources

Covid-19: India approves Russian vaccine Sputnik V for emergency use

India on Monday granted Emergency Use Authorisation (EUA) to Russia's anti-covid vaccine Sputnik V, as the country fights the second wave of coronavirus. The EUA...
IndiaTimes Also reported by •Hindu

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for...
IndiaTimes

Will produce over 850 mn doses in India annually: RDIF after DCGI clears Sputnik V COVID-19 vaccine

The Russian Direct Investment Fund said that India has become the 60th country to approve the Sputnik V coronavirus vaccine. 
Zee News